中文
About Us
Corporate Overview
Management Team
Board of Directors
Contact Us
Our Focus
Metabolic Diseases
Viral Diseases
Cancer
Exploratory Indications
Products&Pipeline
Pipeline
Products
Clinical Trials
Partnership
Investors
Financials & Filing
News
Careers
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Medivir Licenses Exclusive Rights to MIV-802 for Greater China to Ascletis
2017-08-18